You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Swedish Research Council and Vinnova will distribute over 100 million SEK during the coming years to the development of three new centres, with the aim to create strong research and development environments within biopharmaceuticals. This drive is part of an eight year long research programAlready a subscriber Login You have read…
Jacob Tellgren has been appointed Vice President and Global Brand Leader Diabetes at Merck & Co at MSD's headquarter in the US. Tellgren has been CEO of MSD Sweden since Januart 2014 and he is for example responsible for organizing MSD according to the healthcare regions and making the diaAlready a…
The company has appointed Dr Lars Nieba as Chief Technology Officer and a member of the executive management team. Dr Nieba brings 20 years of leadership experience in the development of multiple pharmaceutical product candidates and innovative technologies. His role at Nordic Nanovector will be Already a subscriber Login You…
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer. This collaboration focuses on targeting RMPs, proteins that control many aspects of RNA biology and represeAlready a subscriber Login You have read all your free articles, to continue…
